Active surveillance of patients who have sentinel node positive melanoma : an international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT‐2)
author
Sharma, Avinash
Teras, Roland Martin
statement of authorship
Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett, James Sun, Dennis Kirichenko, Michael J. Carr, Avinash Sharma, Edmund K. Bartlett, Amanda A. G. Nijhuis, John F. Thompson, Tina J. Hieken, Lisa Kottschade, Jennifer Downs, David E. Gyorki, Emma Stahlie, Alexander van Akkooi, David W. Ollila, Jill Frank, Yun Song, Giorgos Karakousis, Marc Moncrieff, Jenny Nobes, John Vetto, Dale Han, Jeffrey M. Farma, Jeremiah L. Deneve, Martin D. Fleming, Matthew C. Perez, Michael C. Lowe, Roger Olofsson Bagge, Jan Mattsson, Ann Y. Lee, Russell S. Berman, Harvey Chai, Hidde M. Kroon, Juri Teras, Roland M. Teras, Norma E. Farrow, Georgia Beasley, Jane Yuet Ching Hui, Lukas Been, Schelto Kruijff, Youngchul Kim, Syeda Mahrukh Hussnain Naqvi, Amod A. Sarnaik, Vernon K. Sondak, Jonathan S. Zager
source
Cancer
publisher
American Cancer Society
journal volume number month
vol. 127, 13
year of publication
pages
p. 2251-2261
subject term
ISSN
1097-0142
Open Access
Open Access
scientific publication
teaduspublikatsioon
classifier
TTÜ department
language
inglise
Broman, K. K., Hughes, T., Dossett, L., Sun, J., Kirichenko, D., Carr, M. J., Sharma, A., Bartlett, E. K., Nijhuis, A. A. G., Thompson, J. F., Teras, J., Teras, R. M. et al. Active surveillance of patients who have sentinel node positive melanoma : an international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT‐2) // Cancer (2021) vol. 127, 13, p. 2251-2261.